Objectives: To examine associations between psychiatric symptomatology and HIV-positive status in adolescents who sought HIV testing at a public health center in Brazil.
Method: In a cross-sectional study, 388 adolescents assessed for their HIV status were also evaluated for psychiatric symptomatology using the Symptom Checklist-90-R (SCL-90-R). The impact of potential confounding variables such as risk behaviors was ascertained using the Brazilian version of the Risk Assessment Battery (RAB).
Results: Overall seropositivity rate was 6.2%. Seropositives had significantly higher scores in all dimensions of psychiatric symptomatology in the SCL-90-R (P < 0.05 and effect sizes > 0.5 in all dimensions). In multiple analyses, with the inclusion of 3 composite variables (sex-risk, drug-risk, and psychiatric symptomatology), only psychiatric symptoms were associated with positive HIV status (OR = 1.88, CI95% = 1.06-3.34; P = 0.032).
Conclusions: Our findings suggest that amongst young people asking for HIV testing in Brazil, seropositivity is associated with psychological symptoms and that screening for the latter would therefore be appropriate in this context.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00787-006-0595-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Altered brain dynamics of facial emotion processing in schizophrenia: a combined EEG/fMRI study.
Schizophrenia (Heidelb)
January 2025
Department of Psychiatry, Psychotherapy and Psychosomatics, Faculty of Medicine, RWTH Aachen, Aachen, Germany.
Facial stimuli are relevant social cues for humans and essential signals for adequate social interaction. Impairments in face processing are well-documented in schizophrenia and linked to symptomatology, yet the underlying neural dynamics remain unclear. Here, we investigated the processing and underlying neural temporal dynamics of task-irrelevant emotional face stimuli using combined EEG/fMRI in 14 individuals with schizophrenia and 14 matched healthy controls.
View Article and Find Full Text PDFReduced Theta Inter-Trial Phase Coherence in Error Processing: A Marker of Neural Dysfunction in Attention Deficit Hyperactivity Disorder.
Psychophysiology
January 2025
Department of Psychology, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Cognitive control deficits and increased intra-subject variability have been well established as core characteristics of attention deficit hyperactivity disorder (ADHD), and there is a growing interest in their expression at the neural level. We aimed to study neural variability in ADHD, as reflected in theta inter-trial phase coherence (ITC) during error processing, a process that involves cognitive control. We examined both traditional event-related potential (ERP) measures of error processing (i.
View Article and Find Full Text PDFAcceptance and commitment therapy group protocol for caregivers of anxious youth: an open trial pilot study.
Front Child Adolesc Psychiatry
September 2024
Department of Psychiatry, University of Massachusetts Chan Medical School, Worcester, MA, United States.
Introduction: Anxiety disorders are common, distressing, and impairing for children and families. Cognitive-behavioral interventions targeting the role of family interactions in child anxiety treatment may be limited by lack of attention to antecedents to parental control; specifically, internal parent factors such as experiential avoidance and cognitive fusion. This pilot study evaluates the preliminary efficacy of a group-delivered caregiver treatment program, ACT for Parents of Anxious Children (ACT-PAC) that targets parental experiential avoidance, cognitive fusion, and child internalizing symptoms.
View Article and Find Full Text PDFPrecision Psychobiotics for Gut-Brain Axis Health: Advancing the Discovery Pipelines to Deliver Mechanistic Pathways and Proven Health Efficacy.
Microb Biotechnol
January 2025
Fonterra Microbiome Research Centre, University College Cork, Cork, Ireland.
Advancing microbiome-gut-brain axis science requires systematic, rational and translational approaches to bridge the critical knowledge gaps currently preventing full exploitation of the gut microbiome as a tractable therapeutic target for gastrointestinal, mental and brain health. Current research is still marked by many open questions that undermine widespread application to humans. For example, the lack of mechanistic understanding of probiotic effects means it remains unclear why even apparently closely related strains exhibit different effects in vivo.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!